๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Macular Degeneration, Dry

Age-related Macular Degeneration of Atrophic Type Treated With Umbilical Cord Blood Enriched With Platelet Plasma. NCT06536062NA1 site๐Ÿ“ Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS ยท Tests: Intravitreal injection of CB-PRP Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration NCT06662162NA13 sites๐Ÿ“ Poway๐Ÿ“ Manchester๐Ÿ“ Lemont i-Lumen Scientific AUS PTY LTD ยท Tests: i-Lumen AMD Personalized Monitoring of Non-foveal, Non-vision Compromising Atrophic Age-related Macular Degeneration With Artificial Intelligence and Identification of Disease Progression NCT06351657n/a7 sites๐Ÿ“ Vienna๐Ÿ“ Dijon๐Ÿ“ Ljubljana Medical University of Vienna Survival of Monocytes Collected From Patients With Atrophic AMD in Retinal Pigmented Epithelium Explants NCT04697095NA2 sites๐Ÿ“ Lyon๐Ÿ“ Lyon Hospices Civils de Lyon ยท Tests: Blood samples SGLT2 Inhibitors in Geographic Atrophy NCT07174687Phase 21 site๐Ÿ“ St Louis Washington University School of Medicine ยท Tests: Dapagliflozin, Matching Placebo Progression of Early Atrophic Lesions NCT05959005n/a1 site๐Ÿ“ Salt Lake City University of Utah ยท Tests: No intervention A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) NCT06635148Phase 2, Phase 3104 sites๐Ÿ“ Tucson๐Ÿ“ Fullerton๐Ÿ“ La Jolla Janssen Research & Development, LLC ยท Tests: JNJ-81201887, Sham Procedure Phase 3 Study to Assess Efficacy, Safety & Tolerability of OCU410 For Geographic Atrophy Secondary to Dry AMD NCT07770828Phase 33 sites๐Ÿ“ Phoenix๐Ÿ“ Erie๐Ÿ“ McAllen Ocugen ยท Tests: OCU410 A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration NCT03178149Phase 120 sites๐Ÿ“ Phoenix๐Ÿ“ Los Angeles๐Ÿ“ Palo Alto Astellas Institute for Regenerative Medicine ยท Tests: ASP7317, tacrolimus, trimethoprim-sulfamethoxazole, Acyclovir, Nystatin Central micrOperimetry and Radial OCT Evaluation in Geographic Atrophy (CORE-GA): a Prospective Pilot Study NCT07556406n/a1 site๐Ÿ“ San Francisco University of California, San Francisco ยท Tests: Optical coherence tomography, Microperimetry A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy NCT06541704Phase 3231 sites๐Ÿ“ Chandler๐Ÿ“ Phoenix๐Ÿ“ Phoenix Regeneron Pharmaceuticals ยท Tests: Pozelimab, Cemdisiran, Placebo Safety and Tolerability of RPE Stem Cell-derived RPE(RPESC-RPE) Transplantation in Patients With Dry Age-related Macular Degeneration (AMD) NCT04627428Phase 1, Phase 23 sites๐Ÿ“ Beverly Hills๐Ÿ“ Palo Alto๐Ÿ“ Ann Arbor Luxa Biotechnology, LLC ยท Tests: RPESC-RPE-4W Safety & Efficacy of Eyecyte-RPEโ„ข in Patients With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration. NCT06394232Phase 1, Phase 23 sites๐Ÿ“ Jฤlna๐Ÿ“ Delhi๐Ÿ“ Hyderabad Eyestem Research Pvt. Ltd. ยท Tests: Eyecyte-RPEโ„ข A Study to Assess the Efficacy and Safety of RO7965032 in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration NCT07851259Phase 25 sites๐Ÿ“ Walnut Creek๐Ÿ“ Winston-Salem๐Ÿ“ Erie Genentech, Inc. ยท Tests: RO7965032, Placebo A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA) NCT07144137n/a19 sites๐Ÿ“ Mountain View๐Ÿ“ Oak Forest๐Ÿ“ Springfield Complement Therapeutics A Registry Study to Assess Photobiomodulation in Dry Age-Related Macular Degeneration (GLOBALIGHT) NCT06351605n/a6 sites๐Ÿ“ Beverly Hills๐Ÿ“ Cincinnati๐Ÿ“ Charleston LumiThera, Inc. ยท Tests: Valedaยฎ Light Delivery System Subthreshold Laser Treatment for Reticular Pseudodrusen Secondary to Age-related Macular Degeneration NCT04847635NA3 sites๐Ÿ“ Genova๐Ÿ“ Milan๐Ÿ“ Rome Ospedale San Raffaele ยท Tests: Pascal Synthesis 577 sub-threshold laser (Topcon Corporation, Tokyo, Japan), Pascal Synthesis 577 sham (Topcon Corporatโ€ฆ Retinal Photoreceptor Outer Segment Length Before and After Light Stimulation - a Pilot Study NCT03921931NA1 site๐Ÿ“ Vienna Medical University of Vienna ยท Tests: White light stimulation A Study to Evaluate KRIYA-825 (VV-14295) in Adults With Geographic Atrophy Secondary to Age-related Macular Degeneration NCT06765980Phase 1, Phase 24 sites๐Ÿ“ Erie๐Ÿ“ Ottawa๐Ÿ“ Tel Aviv Kriya Therapeutics, Inc. ยท Tests: VV-14295 Atrophic Age-related Macular Degeneration Treated With Intravitreal Injections of Umbilical Cord Blood Platelet-rich Plasma NCT05706896NA1 site๐Ÿ“ Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS ยท Tests: Intravitreal injection of CB-PRP Effect of Omega-3 Fatty Acid Supplementation on Dry-AMD Progression NCT05465252NA1 site๐Ÿ“ Shanghai Shanghai General Hospital, Shanghai Jiao Tong University Scโ€ฆ ยท Tests: Krill Oil, Olive Oil Phase 2 Study of ADX-038 in Participants With Geographic Atrophy NCT06990269Phase 283 sites๐Ÿ“ Gilbert๐Ÿ“ Phoenix๐Ÿ“ Bakersfield ADARx Pharmaceuticals, Inc. ยท Tests: ADX-038, Placebo Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degeneration NCT06375239n/a1 site๐Ÿ“ Irvine Ray Therapeutics, Inc. Real-World Evaluation of AI Enabled Multi-Spectral Imaging (MSI) for AMD Biomarker Detection NCT07446582n/a1 site๐Ÿ“ Woodbridge AI-Spectral ยท Tests: Retina imaging device (MSI-120) and AI (DeepMSI AI) A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio NCT07215390Phase 278 sites๐Ÿ“ Gilbert๐Ÿ“ Mesa๐Ÿ“ Phoenix Apellis Pharmaceuticals, Inc. ยท Tests: APL-3007, pegcetacoplan (APL-2), APL-3007, pegcetacoplan (APL-2), Placebo, Syfovre A Study to Evaluate the Safety and Effect of TO-O-1007 Intravitreal Implant in Subjects With Geographic Atrophy NCT07668804Phase 1, Phase 23 sites๐Ÿ“ Hurstville๐Ÿ“ Sydney๐Ÿ“ Launceston Theratocular Biotek Co. ยท Tests: TO-O-1007 (low-dose), TO-O-1007 (high-dose), Sham injection AVIGA3 (Cohort 2.0) NCT07255859NA1 site๐Ÿ“ Singapore Tan Tock Seng Hospital ยท Tests: Amsler Grid, AVIGA Study in Human iPSCs-derived RPE Cells Transplantation for Advanced (Late-stage) AMD NCT07418177Phase 1, Phase 21 site๐Ÿ“ Nanjing The First Affiliated Hospital with Nanjing Medical Universiโ€ฆ ยท Tests: hiPSC-RPEs Safety and Clinical Applicability of Transcorneal Electrical Stimulation (TES) in Geographic Atrophy NCT07531927NA5 sites๐Ÿ“ Hamburg๐Ÿ“ Mรผnchen๐Ÿ“ Stuttgart Okuvision GmbH ยท Tests: Transcorneal electrical stimulation (TES) with the OkuStim 2 System, Transcorneal electrical stimulation (TES) with theโ€ฆ A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration NCT07441642Phase 259 sites๐Ÿ“ Huntington Beach๐Ÿ“ Sacramento๐Ÿ“ Santa Barbara Novartis Pharmaceuticals ยท Tests: FWY003, Placebo
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy